Related Experiment Video
Updated: Mar 21, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated
Majken Wallerius1, Tatjana Wallmann1, Margarita Bartish1
1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden.
Abstract:
Accumulation of tumor-associated macrophages (TAM) correlates with malignant progression, immune suppression, and poor prognosis. In this study, we defined a critical role for the cell-surface guidance molecule SEMA3A in differential proliferative control of TAMs. Tumor cell-derived SEMA3A restricted the proliferation of protumoral M2 macrophages but increased the proliferation of antitumoral M1, acting through the SEMA3A receptor neuropilin 1. Expansion of M1 macrophages in vivo enhanced the recruitment and activation of natural killer (NK) cells and cytotoxic CD8(+) T cells to tumors, inhibiting their growth. In human breast cancer specimens, we found that immunohistochemical levels of SEMA3A correlated with the expression of genes characteristic of M1 macrophages, CD8(+) T cells, and NK cells, while inversely correlating with established characters of malignancy. In summary, our results illuminate a mechanism whereby the TAM phenotype is controlled and identify the cell-surface molecule SEMA3A as a candidate for therapeutic targeting. Cancer Res; 76(11); 3166-78. ©2016 AACR.
Insights
Tumor-associated macrophages (TAMs) drive cancer progression. This study reveals SEMA3A controls TAM proliferation, promoting anti-tumor immunity and potentially offering a new therapeutic target.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Oncology
Background:
- Tumor-associated macrophages (TAMs) are crucial in cancer progression, immune suppression, and poor prognosis.
- Understanding TAM heterogeneity and function is vital for developing effective cancer therapies.
Purpose of the Study:
- To define the role of the guidance molecule SEMA3A in controlling TAM proliferation.
- To investigate the mechanism by which SEMA3A influences TAM phenotypes and anti-tumor immunity.
Main Methods:
- Investigated SEMA3A's effect on M1 and M2 macrophage proliferation in vitro and in vivo.
- Utilized immunohistochemistry to analyze SEMA3A levels in human breast cancer specimens.
- Correlated SEMA3A expression with immune cell markers and malignancy indicators.
Main Results:
- Tumor cell-derived SEMA3A differentially regulated TAM proliferation via its receptor neuropilin 1.
- SEMA3A promoted M1 macrophage expansion while restricting M2 macrophage proliferation.
- M1 macrophage expansion enhanced natural killer (NK) and CD8(+) T cell recruitment and activity, inhibiting tumor growth.
- In human breast cancer, SEMA3A levels correlated with M1, CD8(+) T cell, and NK cell markers, and inversely with malignancy indicators.
Conclusions:
- SEMA3A plays a critical role in controlling TAM phenotype and function.
- The SEMA3A-neuropilin 1 axis modulates anti-tumor immunity by influencing TAM polarization.
- SEMA3A represents a potential therapeutic target for enhancing anti-tumor immune responses in cancer.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mesenchymal Stem Cells

